IFN-γ signaling through the JAK-STAT pathway is not only relevant for cancer immunotherapy, but also underpins pathology in myeloproliferative neoplasms, chronic mucocutaneous candidiasis, primary immunodeficiency, and several inflammatory diseases.1 The gene discussed is IFNG; the disease is cancer.